About
Venture partner and former CEO of Uniseed with nearly two decades of board and executive experience in commercializing early-stage technologies. Has served on boards of startups that collectively raised over AU$300 million, with notable exits including Fibrotech to Shire, Spinifex to Novartis, and Kinoxis' license agreement with Boehringer Ingelheim. Recognized in the 2018 GUV Powerlist as a top global figure in university venturing.